BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

GammaCan International, Inc. 



Givat Shmuel      Israel
Phone: 972-3-53-24-101 Fax:


SEARCH JOBS








 Company News
GammaCan International, Inc. (GCAN.OB) Release: VitiGam(TM) Inhibits Melanoma Growth in a Dose Dependent Manner 8/11/2008 8:19:16 AM    More...
GammaCan International, Inc. (GCAN.OB) Executes Supply Agreement with Bio Products Laboratory to Manufacture VitiGam(TM) for the Treatment of Melanoma for Clinical Testing and Commercial Sale 6/4/2008 8:20:48 AM    More...
GammaCan International, Inc. (GCAN.OB) Announces Positive Testing Results in the Development of VitiGam(TM) for the Treatment of Melanoma 3/6/2008 11:34:24 AM    More...
GammaCan International, Inc. (GCAN.OB) to Present at the Rodman & Renshaw 9th Annual Healthcare Conference 2007 11/5/2007 9:46:32 AM    More...
GammaCan International, Inc. (GCAN.OB) Enters into Vitiligo Plasma Supply Agreement with DCI Biologicals 10/1/2007 9:45:23 AM    More...
Taglich Brothers Initiates Coverage on GammaCan International, Inc. (GCAN.OB) 9/21/2007 8:32:44 AM    More...
GammaCan International, Inc. (GCAN.OB) Receives FDA Orphan Drug Designation for Lead Product VitiGam(TM) for Stage IIB to Stage IV Melanoma 8/7/2007 1:05:31 PM    More...
GammaCan International, Inc. (GCAN.OB) Discovers Anti-Angiogenic Properties in Plasma-Derived IgG; Company Files Patent Application Pertaining to Disorders of Neovascularization Including Cancer and Other Diseases 6/28/2007 1:11:29 PM    More...
GammaCan International, Inc. (GCAN.OB) Retains Investor Relations Firm ROI Group 6/27/2007 1:31:33 PM    More...
GammaCan International, Inc. (GCAN.OB) to Present and Webcast at Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference 5/14/2007 12:09:12 PM    More...
12345

//-->